Making medical decisions is not as easy as following the evidence. When dealing with people, there are a number of anomalies that influence the decisions someone might make.
Making medical decisions is not as easy as following the evidence. When dealing with people, there are a number of anomalies that influence the decisions someone might make, explained Douglas E. Hough, PhD, from Johns Hopkins University, during a plenary session at ISPOR’s annual meeting.
Hough outlined the thought processes that impact someone’s decisions or behaviors and the implications behavioral economics could have in healthcare. He provided 5 examples of anomalies that influence behavior:
These all influence things in healthcare, such as how we fight obesity, how adherent we are to medication, physician engagement and hand offs in the emergency room, and more, Hough concluded.
Kevin Volpp, MD, PhD, of the University of Pennsylvania, discussed the 5000-hour problem, whereby even for patients with a chronic illness who see their doctor multiple times a year, there are 5000-plus hours where these patients are largely on their own. Technology is creating an enormous opportunity for population health, but it cannot work on its own.
“While the technology creates enormous new opportunities in this space, just giving people these devices by themselves is unlikely to change their behavior,” he said. “People who buy these [devices] are typically those who are already motivated and thinking about their health.”
The devices need to be part of a larger ecosystem where patients have a device that uploads information to a health system’s services and either the patient or a social supporter and the provider gets feedback and the information goes into the electronic medical record.
What will ultimately drive change, though? The relationship, said David Meltzer, MD, PhD, of University of Chicago. The literature on patient-doctor relationships has shown the importance of trust, interpersonal relationships, communication, and knowledge of the patient in the form of lower costs and better outcomes.
Males With Hemophilia A Report Physical, Mental Burdens of Disease Regardless of Severity
April 25th 2024Self-reported data from adult and pediatric males with hemophilia A show that burden of the disease persists regardless of severity, highlighting a need for improved prophylactic treatment.
Read More
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More